Sanofi (SNY) Debt to Equity (2016 - 2025)
Sanofi (SNY) has disclosed Debt to Equity for 11 consecutive years, with $0.26 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 26.17% to $0.26 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.26 through Dec 2025, up 26.17% year-over-year, with the annual reading at $0.26 for FY2025, 26.17% up from the prior year.
- Debt to Equity hit $0.26 in Q4 2025 for Sanofi, up from $0.21 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.3 in Q4 2021 to a low of $0.21 in Q4 2024.
- Historically, Debt to Equity has averaged $0.25 across 5 years, with a median of $0.25 in 2022.
- Biggest five-year swings in Debt to Equity: dropped 17.12% in 2021 and later grew 26.17% in 2025.
- Year by year, Debt to Equity stood at $0.3 in 2021, then dropped by 13.93% to $0.25 in 2022, then dropped by 13.0% to $0.22 in 2023, then dropped by 6.76% to $0.21 in 2024, then increased by 26.17% to $0.26 in 2025.
- Business Quant data shows Debt to Equity for SNY at $0.26 in Q4 2025, $0.21 in Q4 2024, and $0.22 in Q4 2023.